4//SEC Filing
Devlin Jodi 4
Accession 0001826667-25-000059
CIK 0001826667other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:31 PM ET
Size
6.3 KB
Accession
0001826667-25-000059
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Common Stock
2025-05-19$5.18/sh+24,131$124,999→ 57,528 total - Sale
Common Stock
2025-05-19$5.18/sh−4,764$24,678→ 52,764 total
Footnotes (2)
- [F1]The granted RSUs vest immediately.
- [F2]The sale of the shares was to cover the tax liability associated with the granted RSUs.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0001992151
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:31 PM ET
- Size
- 6.3 KB